Sign In
Buy SRTS
$2.84
+0 (+0%)
At Close: Jun 03, 2026
Wall Street Analysts See a 39.66% Upside in Sensus Healthcare (SRTS): Can the Stock Really Move This High?
11:00am, Monday, 18'th Nov 2024
The mean of analysts' price targets for Sensus Healthcare (SRTS) points to a 39.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amon
What Makes Sensus Healthcare (SRTS) a Good Fit for 'Trend Investing'
09:50am, Monday, 18'th Nov 2024
Sensus Healthcare (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed thro
This revised news release replaces the one issued on November 14, 2024, contains several non-financial changes throughout and removes the name of and references to a new customer, at the customer's re
Sensus Healthcare: Q3 Results Showed That The Stock Is Undervalued
01:46pm, Friday, 15'th Nov 2024
Sensus Healthcare's Q3 results exceeded expectations with 127% YoY revenue growth and EPS of $0.07, showcasing strong demand recovery and effective management strategies. The Fair Deal Agreement and n
Sensus Healthcare, Inc. (SRTS) Q3 2024 Earnings Call Transcript
06:40pm, Thursday, 14'th Nov 2024
Sensus Healthcare, Inc. (SRTS) Q3 2024 Earnings Call Transcript
Sensus Healthcare, Inc. (SRTS) Surpasses Q3 Earnings and Revenue Estimates
04:26pm, Thursday, 14'th Nov 2024
Sensus Healthcare, Inc. (SRTS) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to loss of $0.09 per share a year a
Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter
12:06pm, Thursday, 14'th Nov 2024
Revenues of $8.8 million compare with $3.9 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $1.6 million compares with negative $1.7 million a year ago Signed a Fair Deal Agr
Sensus Healthcare, Inc. (SRTS) Outperforms Broader Market: What You Need to Know
07:20pm, Thursday, 24'th Oct 2024
Sensus Healthcare, Inc. (SRTS) reachead $6.44 at the closing of the latest trading day, reflecting a +1.58% change compared to its last close.
Sensus Healthcare (SRTS) is on the Move, Here's Why the Trend Could be Sustainable
09:51am, Monday, 07'th Oct 2024
Sensus Healthcare (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed thro
Sensus Healthcare, Inc. (SRTS) Ascends While Market Falls: Some Facts to Note
07:21pm, Tuesday, 01'st Oct 2024
The latest trading day saw Sensus Healthcare, Inc. (SRTS) settling at $5.90, representing a +1.72% change from its previous close.
All You Need to Know About Sensus Healthcare (SRTS) Rating Upgrade to Strong Buy
01:00pm, Tuesday, 01'st Oct 2024
Sensus Healthcare (SRTS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Sensus Healthcare, Inc. (SRTS) Falls More Steeply Than Broader Market: What Investors Need to Know
07:21pm, Friday, 20'th Sep 2024
Sensus Healthcare, Inc. (SRTS) closed at $5.80 in the latest trading session, marking a -1.86% move from the prior day.
Sensus Healthcare, Inc. (SRTS) is a Great Momentum Stock: Should You Buy?
01:01pm, Friday, 30'th Aug 2024
Does Sensus Healthcare, Inc. (SRTS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Sensus Healthcare (SRTS) Stock Outpacing Its Medical Peers This Year?
10:41am, Friday, 30'th Aug 2024
Here is how Sensus Healthcare, Inc. (SRTS) and Assembly Biosciences (ASMB) have performed compared to their sector so far this year.
Recent Price Trend in Sensus Healthcare (SRTS) is Your Friend, Here's Why
09:50am, Friday, 30'th Aug 2024
Sensus Healthcare (SRTS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
